Centiva Capital’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,708
Closed -$214K 2197
2024
Q3
$214K Buy
+13,708
New +$249K 0.01% 1777
2024
Q2
Sell
-13,141
Closed -$205K 2394
2024
Q1
$205K Sell
13,141
-17,331
-57% -$255K 0.01% 1465
2023
Q4
$455K Sell
30,472
-20,936
-41% -$280K 0.03% 1006
2023
Q3
$830K Buy
+51,408
New +$1.48M 0.04% 731
2022
Q3
Sell
-7,045
Closed -$490K 1746
2022
Q2
$490K Buy
+7,045
New +$531K 0.03% 927
2021
Q3
Sell
-1,914
Closed -$425K 1531
2021
Q2
$425K Buy
+1,914
New +$372K 0.03% 893

Other funds holding NVCR